Hans Jenkins
Family Medicine · Farmington, UTNPI 1316932866
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.5% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $957 and has fallen 98.1% since, to $19 in 2025.
Across 79 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$178
- Avanir Pharmaceuticals, Inc.$171
- Supernus Pharmaceuticals, Inc.$165
- AbbVie$92
- Antares Pharma, Inc.$73
- Sunovion Pharmaceuticals Inc.$65
- plus $434 from 15 others
What the payments were for
- Food & beverage$1,07992%
- Education$1008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $178 |
| Avanir Pharmaceuticals, Inc. | 16 | $171 |
| Supernus Pharmaceuticals, Inc. | 13 | $165 |
| AbbVie(2 entities) | 5 | $92 |
| Antares Pharma, Inc. | 5 | $73 |
| Sunovion Pharmaceuticals Inc. | 4 | $65 |
| Alkermes, Inc. | 4 | $64 |
| Johnson & Johnson | 4 | $57 |
| Novartis | 4 | $54 |
| Amgen | 2 | $45 |
| Boston Scientific | 3 | $43 |
| Shire North American Group Inc | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Boehringer Ingelheim | 1 | $20 |
| Braeburn Inc. | 1 | $19 |
| Pfizer | 1 | $17 |
| GSK | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Biogen | 1 | $13 |
| Novo Nordisk | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$1,179 in reported general payments places this provider in the 65th percentile of 928 family medicine providers in Utah.
Other family medicine in Farmington
- Michael CobbleSandy$1.3M
- Thomas ClarkProvidence$332K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- Scott EricksonBountiful$101K
- Mark CacciamaniSalt Lake City$43K
- Clint MowerLehi$41K
- Russell AndersonTooele$30K
- Kirk OdonnellSalt Lake City$23K
- John TemplemanProvo$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.